ZICC — Ziccum AB Share News
0.000.00%
Last trade - 00:00- SEK12.77m
- SEK12.09m
- SEK3.75m
Brief: Ziccum Rights Issue Subscribed For About 38.7%
Brief: Ziccum Says Rights Issue Was Subscribed To About 21.4% Based On Preliminary Outcome
Brief: Ziccum Patent Applications Advance To Percent Stage
Brief: Ziccum Q3 Oper Loss Widens To SEK 5.9 Mln
Brief: Ziccum Intends To Resolve On Rights Issue Of About SEK 30 Mln, Raises Bridge Loan
Brief: Ziccum Announces Outcome Of Exercise Of Warrants Of Series To5
Brief: Ziccum Announces Trademarking Laminarpace In U.S.
Brief: Ziccum Q2 Operating Loss Widens To SEK 7.6 Mln
Brief: Ziccum Investigates Significant Increase In MRNA Activity Achieved With Laminarpace
Brief: Ziccum Signs Evaluation Agreement With ReCode Therapeutics
Brief: Ziccum Partners With DI For Investor Relations Program
Brief: Ziccum Strengthens Patent Portfolio
Brief: Ziccum Q1 Loss Narrows To SEK 4 Mln
Brief: Ziccum CFO To Leave In Reorganisation Process
Brief: Ziccum Q4 Operating Income At SEK 1.6 Mln
Brief: Ziccum Carries Out Directed Share Issue, Rights Issue
Brief: Ziccum Reports Successful Feasibility Study
Brief: Ziccum Signs Agreement For Vaccine Evaluation Project
Brief: Ziccum Q3 Oper Loss Narrows To SEK 3.9 Mln